OriGene

OriGene Technologies, Inc. is a gene centric life sciences company dedicated to support biomedical scientists in gene functions and drug discovery. OriGene’s novel product line includes the world’s largest collections of cDNA clones (TrueClone and TrueORF), shRNA (HuSH-29), purified human recombinant proteins, high quality TrueMAB™ monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is a Luminex Certified Partner™ and offers multiplexed immunoassays and multiplexed assays for a broad range of biomarkers.

sample review
  • Megatrans was used in plasmid transfection in order to study the role of a cascade consisting of GSK3beta, Dzip1, and Rab8 in regulating ciliogenesis after mitosis.
  • Origene scrambled control plasmid was used to perform cell transfection in order to study study the regulation mechanism of protein quality control by UBE4B and LSD1.
  • Origene LSD1 shRNA plasmid was used to perform cell transfection in order to study study the regulation mechanism of protein quality control by UBE4B and LSD1.
  • Origene UBE4B plasmid was used to perform cell transfection in order to study study the regulation mechanism of protein quality control by UBE4B and LSD1.
  • Origene pCMV6-Hes5-gfp plasmid was used to perform cell transfection in order to investigate the role of FBW7 in the Notch signalling pathway.
  • Origene recombinant hnRNP A2/B1 was used to perform protein-protein interaction assays in order to investigate the regulatory effect of HILDA complex on VEGF-A expression.
  • Origene hnRNP L siRNA was used to perform cell transfection in order to investigate the regulatory effect of HILDA complex on VEGF-A expression.
  • Origene pCMV6-AN-tGFP was used to perform gene cloning in order to show that oogenic processes were regulated by MARF1.
  • OriGene empty plasmid was used to perform RNAi in order to show that NLRP3 inflammasome could be regulated by GBP5 in mammals.
  • OriGene GBP5 HuSH-29 shRNA was used to perform RNAi in order to show that NLRP3 inflammasome could be regulated by GBP5 in mammals.
  • Zhongshan Goldenbridge Biotechnology Corporation secondary antibodies were used to perform western blot in order to show that AtCERK1 could be activated through dimerization induced by Chitin.
sample product